Riskpilot← Back to searchSign inGet full accessRoomi Medica AB
ABActiveOrg 5569466880Bollnäsbacken 38Medical specialists activities · NACE 8622Est. 20131 employees
Revenue 2025
SEK 957K
+59% vs 2024
EBITDA margin
74.7%
+125% vs 2024
Equity ratio
55.3%
Financial strength
Net profit 2025
SEK 473K
+153% vs 2024
| Revenue | SEK 957K | +59% |
| EBITDA | SEK 715K | +125% |
| Net profit | SEK 473K | +153% |
| Total assets | SEK 2,2M | +89% |
| Equity | SEK 1,2M | +30% |
| Employees | 1 | — |
Legal name
Roomi Medica AB
Org number
5569466880
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
29 oktober 2013
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-04-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Konsult inom medicin branschen med ortpedisk specialitet. Arbeta inom ortopediska specialitet. Inom öppenvård, bedömning av orto- pedisk fall, utförande av dagkirurgiska operationer samt agera konsult inom ortopedi. Inom slutenvården kommer bedömning och behandling av fraktur samt ledplastikkirurgi att bedrivas.
Address
Bollnäsbacken 38
Phone
+46707146026
Email
farisroomi88@yahoo.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 347 | 440 | 451 | 603 | 957 |
| Staff expenses | — | −94 | −50 | −68 | −48 |
| EBITDA | −49 | 216 | 102 | 317 | 715 |
| Depreciation & amort. | −0 | — | — | — | −31 |
| EBIT | −49 | 216 | 102 | 317 | 684 |
| Net financials | — | −0 | 551 | 6 | 7 |
| Profit before tax | 1 | 160 | 654 | 239 | 602 |
| Tax | −1 | −34 | −13 | −52 | −129 |
| Net profit | 0 | 126 | 641 | 187 | 473 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 995 | 1 021 | 1 454 | 1 144 | 2 158 |
| Equity | 568 | 494 | 935 | 921 | 1 194 |
| Long-term debt | 0 | — | — | −500 | 0 |
| Short-term debt | 308 | 352 | 345 | 464 | 616 |
| Total debt | 308 | 352 | 345 | −36 | 616 |
EBITDA margin
74.7%
This company
15.8%
Market median
+373% vs market
20212025
Equity ratio
55.3%
This company
38.2%
Market median
+45% vs market
20212025
Return on equity
39.6%
This company
18.4%
Market median
+115% vs market
20212025
Net profit margin
49.4%
This company
8.1%
Market median
+510% vs market
20212025
Asset turnover
0.44×
This company
1.12×
Market median
-61% vs market
20212025
Debt / equity
0.81×
This company
0.62×
Market median
+31% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-05-01 – 2021-04-30
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (5) | ||
| Deputy Board Member | 2026 | |
| Deputy Board Member | 2022 | |
| Chairman | 2026 | |
| Deputy Board Member | 2026 | |
| Board of Directors | 2026 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Roomi Medica AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Mukarram Roomi | Deputy Board Member | 0 companies |
| Saba Majid | Deputy Board Member | 0 companies |
| Faris Sheetal Roomi | Chairman | 0 companies |
| Toto Laith Roomi | Deputy Board Member | 0 companies |
| Saba Majid | Board of Directors | 0 companies |